Ozieranski K., Tyminska A., Jonik S. et al. (2021) Clini-
cally Suspected Myocarditis in the Course of Severe Acute Respiratory
Syndrome Novel Coronavirus-2 Infection: Fact or Fiction? J. Card. Fail,
Vol. 27(1): 92–96. doi: 10.1016/j.cardfail.2020.11.002.
59.
Palmisano A., Benedetti G., Faletti R. et al. (2020) Early
T1 Myocardial MRI Mapping: Value in Detecting Myocardial Hyperemia
in Acute Myocarditis. Radiology, Vol. 295(2): 316–325. doi: 10.1148/ra-
diol.2020191623.
60.
Peretto G., Sala S., Rizzo S. et al. (2019) Arrhythmias in myo-
carditis: state of the art. Heart Rhythm Case Reports., Vol. 16 (5): 793–
801. doi.org/10.1016/j.hrthm.2018.11.024.
61.
Pinto Y.M., Elliott P.M., Arbustini E. et al. (2016) Proposal
for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated
cardiomyopathy, and its implications for clinical practice: a position state-
ment of the ESC working group on myocardial and pericardial diseases.
Eur. Heart J., Vol. 37 (23): 1850–1858. doi: 10.1093/eurheartj/ehv727.
62.
Ponikowski P., Voors A.A., Anker S.D. et al. (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and
chronic heart failure. Eur. Heart J., Vol. 37: 2129—2200. doi:10.1093/
eurheartj/ehw128.
63.
Qin F., Yan Y., Liu T. et al. (2016) Immunosuppressive treat-
ment for myocarditis: a meta-analysis of randomized controlled tri-
als. J. Cardiovasc. Med. Hagerstown., Vol. 17(8): 631–7. doi: 10.2459/
JCM.0000000000000134.
64.
Robinson J., Hartling L., Vandermeer B. et al. (2015) In-
travenous immunoglobulin for presumed viral myocarditis in children
and adults. Cochrane Database Syst. Rev., Vol. 20(5): CD004370. doi:
10.1002/14651858.CD00437.
65.
Rose N.R. (2011) Critical cytokine pathways to cardiac inflamma-
tion. J. Interferon. Cytok. Res., Vol. 31: 705–9. doi: 10.1089/jir.2011.0057
66.
